Transcenta Holding Limited (HKG:6628)
Hong Kong · Delayed Price · Currency is HKD 0.7150
-0.0200 (-2.72%)
Nov 3, 2026, 4:08 PM HKT
Transcenta Holding Market Cap
Transcenta Holding has a market cap or net worth of 305.27 million as of November 3, 2026. It is the 31,841st most valuable company in the world and the 1,646th biggest in Hong Kong. Its market cap has decreased by 77.90% in one year.
Market Cap
305.27M
Enterprise Value
460.30M
Revenue
32.70M
Global Rank
Country Rank
#1,646 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since April 27, 2022, Transcenta Holding's market cap has decreased from 2.75B to 305.27M, a decrease of -88.92%. That is a compound annual growth rate of -38.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 305.27M | -67.99% |
| Dec 31, 2025 | 953.77M | 274.36% |
| Dec 31, 2024 | 254.77M | -82.96% |
| Dec 29, 2023 | 1.50B | 14.88% |
| Dec 30, 2022 | 1.30B | -52.74% |
| Apr 27, 2022 | 2.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| JW (Cayman) Therapeutics Co. | 901.09M |
| Wuhan YZY Biopharma | 775.40M |
| Brii Biosciences | 707.42M |
| Kintor Pharmaceutical | 666.64M |
| 3D Medicines | 641.85M |
| Sirnaomics | 449.75M |
| Uni-Bio Science Group | 394.10M |
| B&K Corporation | 384.74M |